DIGIFab® Rapidly Binds and Neutralises Digoxin and other Cardiac Glycosides1,2
- DIGIFab® neutralises free digoxin within minutes to resolve the cardiotoxic effects and other clinical manifestations of life-threatening digoxin toxicity.2,6*
Results from a prospective, multicentre safety, efficacy, and pharmacokinetic study in patients presenting with life-threatening digoxin toxicity (N=15) conducted in the United States and Finland. Results were compared with historical data on Digibind®. Patients received doses of DIGIFab® based on its theoretical binding capacity for digoxin and based on the known amount of digoxin ingested or on blood concentrations of digoxin at the time of admission.
